Gene therapy of cancer : (Record no. 651571)

MARC details
000 -LEADER
fixed length control field 14163cam a22008174a 4500
001 - CONTROL NUMBER
control field ocm52314871
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250702164221.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |n|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 990714s2000 njua ob 001 0 eng c
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 99038474
040 ## - CATALOGING SOURCE
Original cataloging agency COO
Language of cataloging eng
Description conventions pn
Transcribing agency COO
Modifying agency N$T
-- YDXCP
-- CUV
-- ZCU
-- GW5XE
-- CUS
-- YNG
-- CSU
-- OCLCQ
-- PUL
-- CNTRU
-- OCLCE
-- E7B
-- CASUM
-- IDEBK
-- OCLCQ
-- OCLCO
-- OCLCF
-- OCLCQ
-- AZU
-- OCLCQ
-- EUW
-- OCLCQ
-- OCL
-- OCLCQ
-- VT2
-- OCLCA
-- OTZ
-- STF
-- OCLCO
-- OCLCA
-- BUF
-- OCLCO
-- MERER
-- KIJ
-- OCLCO
-- OCLCQ
-- OCLCO
-- OCLCQ
-- U3W
-- OCLCQ
-- UWO
-- YOU
-- CANPU
-- OCLCQ
-- OCLCO
-- AU@
-- OCLCO
-- OCLCQ
-- OCLCO
-- GW5XE
-- U3G
-- S2H
-- OCLCA
-- OCL
-- OCLCA
-- INARC
-- OCLCQ
-- U9X
-- OCLCO
-- OCLCQ
-- WSU
-- OCLCO
-- OCLCL
-- OCLCQ
019 ## -
-- 232301989
-- 320972107
-- 505721968
-- 606281815
-- 609341201
-- 642459997
-- 771201737
-- 964889446
-- 967616717
-- 994752149
-- 1005828701
-- 1027508621
-- 1045331211
-- 1050763795
-- 1055341350
-- 1066975281
-- 1078128557
-- 1078834637
-- 1078846975
-- 1081197490
-- 1086440314
-- 1087323777
-- 1117245378
-- 1119430633
-- 1148142134
-- 1152975318
-- 1153287623
-- 1154212217
-- 1228597752
-- 1264879448
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781592590865
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0896038432
Qualifying information (comb ;
-- alk. paper)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780896038431
Qualifying information (comb ;
-- alk. paper)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1592590861
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9780896037144
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 0896037142
Qualifying information (hard ;
-- alk. paper)
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1385/1592590861
Source of number or code doi
029 1# - (OCLC)
OCLC library identifier NZ1
System control number 15211679
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)52314871
Canceled/invalid control number (OCoLC)232301989
-- (OCoLC)320972107
-- (OCoLC)505721968
-- (OCoLC)606281815
-- (OCoLC)609341201
-- (OCoLC)642459997
-- (OCoLC)771201737
-- (OCoLC)964889446
-- (OCoLC)967616717
-- (OCoLC)994752149
-- (OCoLC)1005828701
-- (OCoLC)1027508621
-- (OCoLC)1045331211
-- (OCoLC)1050763795
-- (OCoLC)1055341350
-- (OCoLC)1066975281
-- (OCoLC)1078128557
-- (OCoLC)1078834637
-- (OCoLC)1078846975
-- (OCoLC)1081197490
-- (OCoLC)1086440314
-- (OCoLC)1087323777
-- (OCoLC)1117245378
-- (OCoLC)1119430633
-- (OCoLC)1148142134
-- (OCoLC)1152975318
-- (OCoLC)1153287623
-- (OCoLC)1154212217
-- (OCoLC)1228597752
-- (OCoLC)1264879448
037 ## - SOURCE OF ACQUISITION
Source of stock number/acquisition 00012511
042 ## - AUTHENTICATION CODE
Authentication code pcc
-- dlr
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC271.G45
Item number G484 2000
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QZ 266
Item number G3259 2000
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 062000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code HEA
Subject category code subdivision 039030
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MJCL
Source bicssc
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.99/4042
Edition number 21
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Gene therapy of cancer :
Remainder of title methods and protocols /
Statement of responsibility, etc. edited by Wolfgang Walther and Ulrike Stein.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. Totowa, N.J. :
Name of publisher, distributor, etc. Humana Press,
Date of publication, distribution, etc. ©2000.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xvi, 645 pages) :
Other physical details illustrations
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES STATEMENT
Series statement Methods in molecular medicine ;
Volume/sequential designation 35
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
500 ## - GENERAL NOTE
General note Immunizing potential of cytokine-transduced tumor cells / M.P. Colombo and M. Rodolfo-Particle-mediated gene transfer into dendritic cells : A novel strategy for the induction of immune responses against tumor antigens / T. Tuting and A. Albers-Cancer gene therapy with heat shock protein-65 gene / K.V. Lukacs and A. Nakakes-Recombinant vaccinia virus mva for generation and analysis of t cell responses against tumor associated antigens / I. Drexler [and others]-Selection of cytochrome p450 genes for use in prodrug activation-based cancer gene therapy / J.E. Hecht and D.J. Waxman-Construction of p450-expressing tumor cell lines using retroviruses / J.E. Hecht, Y. Jounaidi and D.J. Waxman-7 in vitro methods for evaluation of p450-based anticancer gene therapy / D.H. JE and D.J. Waxman-8 tumor models for evaluation of p450 gene therapy in vivo / J.E. Hecht, P. Schreiber Schwartz and D.J. Waxman-9 intracellular single-chain antibodies for gene therapy / G. Bilbao [and others]-Combined adenoviral transfer of tumor suppressor and cell-cycle genes for tumor-cell apoptosis / K. Brand, V. Sandig and M. Strauss-Inhibition of cell growth by antisense oligonucleotides targeting the growth-related protein kinase c-raf / D. Fabbro [and others]-Igf-1 antisense strategies for cancer treatment / Y.X. Pan and D.D. Anthony-Anti-mdr1 ribozyme gene therapy / T. Ohnuma, H. Kobayashi and F.S. Wang-Anti-c-erb1b2 ribozyme for gene therapy of breast cancer / T. Suzuki, M. Bessho and K.J. Scanlon-Anti-k-ras1 ribozyme adenoviral vector for gene therapy of non-small cell lung cancer / Y.A. Zhang, J. Nemunaitis and A.W. Tong-Green fluorescent protein retroviral vector : Generation of high-titer producer cells and virus supernatant / W. Uckert, L. Pedersen and W. Gunzburg-Hsv-1 vectors for gene therapy of experimental cns tumors / U. Herrlinger [and others]-Intratumoral injection of naked DNA / J. Yang-Cationic liposome gene transfer / K. Kay Son-In vivo particle-mediated gene transfer for cancer therapy / A.L. Rakhmilevich and N.S. Yang-Gene targeting to hepatomas (afp) / S. Tsuruta, A. Ido and S. Nagataki-Adenovirus-mediated targeted gene therapy for breast cancer and for purging hematopoietic stem-cell sources / L. Chen-Chemotherapy-inducible vector for gene therapy of cancer / W. Walther [and others]-Oncolytic adenoviral vectors / R. Alemany and W.W. Zhang-Genetically modified clostridium for gene therapy of tumors / M.E. Fox [and others]-Tumor-targeted salmonella: Strain development and expression of the hsv-tk effector gene / D. Bermudes, B. Low and J.M. Pawelek-Ex vivo cytokine gene transfer in melanomas by using particle bombardment / D. Schadendorf-Intratumoral gene transfer of the hla-b7 gene into colon carcinoma metastases / E. Galanis and J. Rubin-Hybrid cell vaccination in patients with metastatic melanoma / U. Trefzer [and others]-Retroviral transfer of the herpes simplex virus-thymidine kinase (hsv-tk) gene for the treatment of cancer / R. Ramesh [and others]-Gene therapy for treatment of brain tumors (hsv-tkin vivo gene transfer) : A case study / F. Weber, F. Floeth and H. Bojar-Gene therapy of glioblastoma multiforme with a bicistronic retroviral vector expressing human il-2 and hsv-tk / G. Palu [and others]-Intratumoral gene transfer of the cytosine deaminase gene for the treatment of breast cancer / H.S. Pandha and N.R. Lemoine-Adenovirus-mediated wild-type p53 gene transfer into head and neck cancers / G.L. Clayman, D.K. Frank and P.A. Bruso-Direct DNA injection (p53) into hcc tumors / R.R. Mitry and N.A. Habib-A phase ii trial of intratumoral injection with a selectively replicating adenovirus (onyx-015) in patients with recurrent, refractory squamous cell carcinoma of the head and neck / D.H. Kirn-C-myb antisense oligonucleotide therapeutics for hematologic malignancies / S. Luger-Ovarian cancer gene therapy with brca1-an overview / P.S. Obermiller and J.T. Holt-Methods for chemoprotection and chemosensitization : Mdr-1 for chemoprotection using retroviruses to modify hematopoietic cells and cytosine deaminase for chemosensitization using adenoviral vectors to modify epithelian neoplastic cells / S. Shrimdkandada [and others].
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Immunizing potential of cytokine-transduced tumor cells / M.P. Colombo and M. Rodolfo-Particle-mediated gene transfer into dendritic cells : A novel strategy for the induction of immune responses against tumor antigens / T. Tuting and A. Albers-Cancer gene therapy with heat shock protein-65 gene / K.V. Lukacs and A. Nakakes-Recombinant vaccinia virus mva for generation and analysis of t cell responses against tumor associated antigens / I. Drexler [and others]-Selection of cytochrome p450 genes for use in prodrug activation-based cancer gene therapy / J.E. Hecht and D.J. Waxman-Construction of p450-expressing tumor cell lines using retroviruses / J.E. Hecht, Y. Jounaidi and D.J. Waxman-7 in vitro methods for evaluation of p450-based anticancer gene therapy / D.H. JE and D.J. Waxman-8 tumor models for evaluation of p450 gene therapy in vivo / J.E. Hecht, P. Schreiber Schwartz and D.J. Waxman-9 intracellular single-chain antibodies for gene therapy / G. Bilbao [and others]-Combined adenoviral transfer of tumor suppressor and cell-cycle genes for tumor-cell apoptosis / K. Brand, V. Sandig and M. Strauss-Inhibition of cell growth by antisense oligonucleotides targeting the growth-related protein kinase c-raf / D. Fabbro [and others]-Igf-1 antisense strategies for cancer treatment / Y.X. Pan and D.D. Anthony-Anti-mdr1 ribozyme gene therapy / T. Ohnuma, H. Kobayashi and F.S. Wang-Anti-c-erb1b2 ribozyme for gene therapy of breast cancer / T. Suzuki, M. Bessho and K.J. Scanlon-Anti-k-ras1 ribozyme adenoviral vector for gene therapy of non-small cell lung cancer / Y.A. Zhang, J. Nemunaitis and A.W. Tong-Green fluorescent protein retroviral vector : Generation of high-titer producer cells and virus supernatant / W. Uckert, L. Pedersen and W. Gunzburg-Hsv-1 vectors for gene therapy of experimental cns tumors / U. Herrlinger [and others]-Intratumoral injection of naked DNA / J. Yang-Cationic liposome gene transfer / K. Kay Son-In vivo particle-mediated gene transfer for cancer therapy / A.L. Rakhmilevich and N.S. Yang-Gene targeting to hepatomas (afp) / S. Tsuruta, A. Ido and S. Nagataki-Adenovirus-mediated targeted gene therapy for breast cancer and for purging hematopoietic stem-cell sources / L. Chen-Chemotherapy-inducible vector for gene therapy of cancer / W. Walther [and others]-Oncolytic adenoviral vectors / R. Alemany and W.W. Zhang-Genetically modified clostridium for gene therapy of tumors / M.E. Fox [and others]-Tumor-targeted salmonella: Strain development and expression of the hsv-tk effector gene / D. Bermudes, B. Low and J.M. Pawelek-Ex vivo cytokine gene transfer in melanomas by using particle bombardment / D. Schadendorf-Intratumoral gene transfer of the hla-b7 gene into colon carcinoma metastases / E. Galanis and J. Rubin-Hybrid cell vaccination in patients with metastatic melanoma / U. Trefzer [and others]-Retroviral transfer of the herpes simplex virus-thymidine kinase (hsv-tk) gene for the treatment of cancer / R. Ramesh [and others]-Gene therapy for treatment of brain tumors (hsv-tkin vivo gene transfer) : A case study / F. Weber, F. Floeth and H. Bojar-Gene therapy of glioblastoma multiforme with a bicistronic retroviral vector expressing human il-2 and hsv-tk / G. Palu [and others]-Intratumoral gene transfer of the cytosine deaminase gene for the treatment of breast cancer / H.S. Pandha and N.R. Lemoine-Adenovirus-mediated wild-type p53 gene transfer into head and neck cancers / G.L. Clayman, D.K. Frank and P.A. Bruso-Direct DNA injection (p53) into hcc tumors / R.R. Mitry and N.A. Habib-A phase ii trial of intratumoral injection with a selectively replicating adenovirus (onyx-015) in patients with recurrent, refractory squamous cell carcinoma of the head and neck / D.H. Kirn-C-myb antisense oligonucleotide therapeutics for hematologic malignancies / S. Luger-Ovarian cancer gene therapy with brca1-an overview / P.S. Obermiller and J.T. Holt-Methods for chemoprotection and chemosensitization : Mdr-1 for chemoprotection using retroviruses to modify hematopoietic cells and cytosine deaminase for chemosensitization using adenoviral vectors to modify epithelian neoplastic cells / S. Shrimdkandada [and others].
506 ## - RESTRICTIONS ON ACCESS NOTE
Materials specified Use copy
Standardized terminology for access restriction Restrictions unspecified
Source of term star
Institution to which field applies MiAaHDL
533 ## - REPRODUCTION NOTE
Type of reproduction Electronic reproduction.
Place of reproduction [Place of publication not identified] :
Agency responsible for reproduction HathiTrust Digital Library,
Date of reproduction 2010.
Institution to which field applies MiAaHDL
538 ## - SYSTEM DETAILS NOTE
System details note Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
Uniform Resource Identifier <a href="http://purl.oclc.org/DLF/benchrepro0212">http://purl.oclc.org/DLF/benchrepro0212</a>
Institution to which field applies MiAaHDL
583 1# - ACTION NOTE
Action digitized
Time/date of action 2010
Jurisdiction HathiTrust Digital Library
Status committed to preserve
Source of term pda
Institution to which field applies MiAaHDL
520 ## - SUMMARY, ETC.
Summary, etc. In Gene Therapy of Cancer: Methods and Protocols, Wolfgang Walther and Ulrike Stein survey the rapidly evolving field cancer gene therapy and provide a broad array of leading-edge protocols for the delivery of therapeutic genes into tumors. Described in step-by-step fashion and enriched with each author's own practical tips, these readily reproducible methods are currently being widely applied in cancer gene therapy investigations, including immunotherapy and tumor vaccination, suicide gene therapy, antioncogene therapy, and antisense and ribozyme gene therapy. Representative strategies are provided for gene targeting and for viral or nonviral gene delivery in cancer therapy, as well as a significant number of clinical protocols for the development of novel cancer gene therapies. Gene Therapy of Cancer: Methods and Protocols offers basic and clinical researchers a broad ranging overview and collection of the most recent advances in gene transfer techniques. Written by leading international authorities, its readily reproducible, cutting-edge methods constitute today's most valuable tools for the study of cancer gene therapy in both the laboratory and clinical trials.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cancer
General subdivision Gene therapy
Form subdivision Laboratory manuals.
9 (RLIN) 80619
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Neoplasms
General subdivision therapy
9 (RLIN) 80620
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Genetic Therapy
General subdivision methods
9 (RLIN) 80621
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cancer
General subdivision Thérapie génique
Form subdivision Manuels de laboratoire.
9 (RLIN) 80622
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Oncology.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element HEALTH & FITNESS
General subdivision Diseases
-- Cancer.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cancer
General subdivision Gene therapy
Source of heading or term fast
9 (RLIN) 80625
650 17 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Wetenschappelijke technieken.
Source of heading or term gtt
655 #2 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Laboratory Manual
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Handbooks and manuals
Source of term fast
9 (RLIN) 6671
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Laboratory manuals.
Source of term lcgft
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Manuels de laboratoire.
Source of term rvmgf
9 (RLIN) 966128
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Walther, Wolfgang.
9 (RLIN) 80627
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stein, Ulrike.
9 (RLIN) 80628
773 0# - HOST ITEM ENTRY
Title Springer Protocols
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Title Gene therapy of cancer.
Place, publisher, and date of publication Totowa, N.J. : Humana Press, ©2000
International Standard Book Number 0896037142
Record control number (DLC) 99038474
-- (OCoLC)41945019
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Methods in molecular medicine ;
Volume number/sequential designation 35.
9 (RLIN) 79864
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://link-springer-com.libraryproxy.ist.ac.at/10.1385/1592590861">https://link-springer-com.libraryproxy.ist.ac.at/10.1385/1592590861</a>
938 ## -
-- ebrary
-- EBRY
-- ebr10181250
938 ## -
-- EBSCOhost
-- EBSC
-- 46923
938 ## -
-- Internet Archive
-- INAR
-- genetherapyofcan0000unse
938 ## -
-- YBP Library Services
-- YANK
-- 2360017
994 ## -
-- 92
-- ATIST
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection code Home library Current library Date acquired Total Checkouts Date last seen Price effective from Koha item type
  Not Lost     eBook Protocols e-Library e-Library 03/08/2022   03/08/2022 03/08/2022 eBook

Powered by Koha